By Clifford Hwang
Perhaps it is due to the long hours that tax attorneys have
put in at the office these past two weeks since the Treasury Department
introduced new tax-inversion rules, but it finally seems that there may be
clarification of these rules soon. These
tax-inversion
rules, which were introduced on April 4, had threatened to curb some
cross-border mergers and did
curb the Pfizer-Allergan deal. The
rules will hopefully be clarified as Canada’s
Mitel Networks Corp attempts to merge with the U.S.’s Polycom Inc. for $1.96
billion, which is anticipated to present significant tax savings. Perhaps the Treasury will offer even more
guidance if
and when someone files suit against the administration to challenge this rule.
0 comments:
Post a Comment